Ziphius Vaccines is a self-amplifying RNA company developing vaccines for infectious diseases and gene supplementation therapies, aiming to create a new generation of medical tools.
Infectious diseases
ZIP-1642
SARS-CoV-2
Program
Indication
Discovery
Preclinical
Phase 1
Phase 2
Phase 3
ZIP-1642
SARS-CoV-2
ZIP-019
Dengue
Program
Indication
Discovery
Preclinical
Phase 1
Phase 2
Phase 3
ZIP-019
Dengue
ZIP-008
Chlamydia trachomatis
Program
Indication
Discovery
Preclinical
Phase 1
Phase 2
Phase 3
ZIP-008
Chlamydia trachomatis
ZIP-009
Undisclosed
Program
Indication
Discovery
Preclinical
Phase 1
Phase 2
Phase 3
ZIP-009
Undisclosed
Protein enhancement therapy
ZIP-016
Cystic Fibrosis
Program
Indication
Discovery
Preclinical
Phase 1
Phase 2
Phase 3
ZIP-016
Cystic Fibrosis
Partnering
Product Partnering
Partnerships with Ziphius can be made to develop LNP-encapsulated saRNA based vaccines on an out-licensing or risk-sharing basis.
Technology Partnering
Ziphius seeks collaborations to explore its various platform technologies in various disease areas.